16-89740803-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000135.4(FANCA):c.3828+1G>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000135.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF276 | NM_001113525.2 | c.*2557C>G | 3_prime_UTR_variant | 11/11 | ENST00000443381.7 | NP_001106997.1 | ||
FANCA | NM_000135.4 | c.3828+1G>C | splice_donor_variant, intron_variant | ENST00000389301.8 | NP_000126.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF276 | ENST00000443381.7 | c.*2557C>G | 3_prime_UTR_variant | 11/11 | 1 | NM_001113525.2 | ENSP00000415836.2 | |||
FANCA | ENST00000389301.8 | c.3828+1G>C | splice_donor_variant, intron_variant | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250496Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135440
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1460886Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 6AN XY: 726746
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74280
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 12, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 26, 2024 | - - |
Fanconi anemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change affects a donor splice site in intron 38 of the FANCA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is present in population databases (no rsID available, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with clinical features of Fanconi anemia (PMID: 29098742; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 456123). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
FANCA-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2024 | The FANCA c.3828+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant is predicted to abolish the consensus exon 38 splice donor site according to available splice prediction programs (Alamut Visual plus v1.6.1) and has been reported in a patient with Fanconi anemia who also harbored a large deletion of the FANCA gene presumably on the opposite chromosome (Kimble et al. 2018. PubMed ID: 29098742). A different variant affecting the same splice site, c.3828+1G>T has also been reported to cause FA (Castella et al. 2011. PubMed ID: 21273304) suggesting that disruption of the exon 38 splice donor site is not tolerated. This variant is reported in 0.0031% of alleles in individuals of European (Non-Finnish) descent in gnomAD and is interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/456123/). Variants that disrupt the consensus splice donor site in FANCA are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at